BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12589104)

  • 21. Late onset uveitis in juvenile-type chronic polyarthritis controlled with prednisolone, cyclosporin A and methotrexate.
    Kotaniemi K
    Clin Exp Rheumatol; 1998; 16(4):469-71. PubMed ID: 9706430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive drug therapy.
    McCune WJ; Vallance DK; Lynch JP
    Curr Opin Rheumatol; 1994 May; 6(3):262-72. PubMed ID: 8060760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of methotrexate in inflammatory myopathies.
    Fendler C; Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S164-7. PubMed ID: 21044453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstitial alveolitis as early manifestation of anti-Jo-1 positive polymyositis.
    Löhr HF; Böcher WO; Hermann E; Müller-Quernheim J; Schwickert H; Meyer zum Büschenfelde KH; Gerken G
    Z Rheumatol; 1993; 52(5):307-11. PubMed ID: 8259723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe cardiac involvement in children with systemic sclerosis and myositis.
    Quartier P; Bonnet D; Fournet JC; Bodemer C; Acar P; Ouachée-Chardin M; Le Bidois J; Prieur AM
    J Rheumatol; 2002 Aug; 29(8):1767-73. PubMed ID: 12180742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic strategies in idiopatic inflammatory myopathies].
    Chakour R; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 28. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.
    Schiopu E; Phillips K; MacDonald PM; Crofford LJ; Somers EC
    Arthritis Res Ther; 2012 Jan; 14(1):R22. PubMed ID: 22284862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the efficacy and toxicity of the cyclosporine A-flucortolone-methotrexate combination in the treatment of sarcoidosis.
    Pia G; Pascalis L; Aresu G; Rosetti L; Ledda MA
    Sarcoidosis Vasc Diffuse Lung Dis; 1996 Sep; 13(2):146-52. PubMed ID: 8893384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlap.
    Ponyi A; Constantin T; Dankó K
    Clin Rheumatol; 2004 Aug; 23(4):371-2. PubMed ID: 15293105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pulmonary involvement in polymyositis, case report].
    Todea D; Godard P
    Pneumologia; 2001; 50(3):182-7. PubMed ID: 11977491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis.
    Vencovský J; Jarosová K; Machácek S; Studýnková J; Kafková J; Bartůnková J; Nemcová D; Charvát F
    Scand J Rheumatol; 2000; 29(2):95-102. PubMed ID: 10777122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New therapeutic approaches for polymyositis and dermatomyositis].
    Dankó K; Vincze M
    Orv Hetil; 2011 Sep; 152(39):1552-9. PubMed ID: 21920841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
    Maeda K; Kimura R; Komuta K; Igarashi T
    Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells.
    Barbasso Helmers S; Englund P; Engström M; Ahlin E; Fathi M; Janciauskiene S; Heimbürger M; Rönnelid J; Lundberg IE
    Arthritis Rheum; 2009 Aug; 60(8):2524-30. PubMed ID: 19644880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long-term outcome of anti-Jo-1-positive inflammatory myopathies.
    Späth M; Schröder M; Schlotter-Weigel B; Walter MC; Hautmann H; Leinsinger G; Pongratz D; Müller-Felber W
    J Neurol; 2004 Jul; 251(7):859-64. PubMed ID: 15258790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of adult idiopathic inflammatory myopathies with conventional immunosuppressive drugs : Results of a retrospective study.
    Keyßer G; Zierz S; Kornhuber M
    Z Rheumatol; 2019 Mar; 78(2):183-189. PubMed ID: 29713867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biological therapy in sympathetic ophthalmia refractory to combined immunosuppressive treatment].
    López-Prats MJ; Salom D; Sanz-Marco E; García-Delpech S; Udaondo P; Díaz-Llopis M
    Arch Soc Esp Oftalmol; 2011 Jul; 86(7):222-3. PubMed ID: 21798409
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis.
    Kitahara K; Kawai S
    Curr Opin Rheumatol; 2007 May; 19(3):238-45. PubMed ID: 17414949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.